RSV Prefusion F Vaccine for Prevention of Hospitalization in Older Adults
Among adults 60 years of age or older, the RSVpreF vaccine reduced the incidence of hospitalization for RSV-related respiratory tract disease as compared with no vaccine. (Funded by Pfizer; European Union Clinical Trials number, 2024-516600-42-00; DAN-RSV ClinicalTrials.gov number, NCT06684743.).
Authors
- Brian Lee Claggett (ORCID: https://orcid.org/0000-0002-4215-9218)
- Lothar Wiese (ORCID: https://orcid.org/0000-0003-2719-1743)
- Caroline Espersen (ORCID: https://orcid.org/0000-0003-2879-8862)
- Camilla Ikast Ottosen (ORCID: https://orcid.org/0000-0002-8446-6216)
- Mette Skovdal (ORCID: https://orcid.org/0000-0002-6642-0345)
- Anne Marie Reimer Jensen (ORCID: https://orcid.org/0000-0003-3272-636X)
- Kristoffer Grundtvig Skaarup (ORCID: https://orcid.org/0000-0002-2690-7511)
- Güldas Köse (ORCID: https://orcid.org/0000-0003-0617-0177)
- Lars Køber (ORCID: https://orcid.org/0000-0002-6635-1466)
- Mats Christian Højbjerg Lassen (ORCID: https://orcid.org/0000-0002-2255-582X)
- Matias Greve Lindholm (ORCID: https://orcid.org/0009-0008-3610-8837)
- Jens‐Ulrik Stæhr Jensen (ORCID: https://orcid.org/0000-0003-4036-0521)
- Negar Aliabadi (ORCID: https://orcid.org/0000-0002-9264-5089)
- Scott David Solomon (ORCID: https://orcid.org/0000-0003-3698-9597)
- Filip Soeskov Davidovski (ORCID: https://orcid.org/0000-0002-6642-416X)
- Lisa Steen Duus (ORCID: https://orcid.org/0000-0003-4110-3199)
- Carsten Schade Larsen (ORCID: https://orcid.org/0000-0002-3963-3804)
- Anne Bjerg Nielsen (ORCID: https://orcid.org/0000-0002-0624-5936)
- Daniel Modin (ORCID: https://orcid.org/0000-0002-7566-0519)
- Maria Dons (ORCID: https://orcid.org/0000-0003-3506-6862)
- Cyril Jean‐Marie Martel (ORCID: https://orcid.org/0009-0004-3371-6870)
- Michael Dalager‐Pedersen (ORCID: https://orcid.org/0000-0002-3220-2526)
- Elizabeth Begier (ORCID: https://orcid.org/0000-0002-1287-5416)
- Niklas Dyrby Johansen (ORCID: https://orcid.org/0000-0001-6959-3236)
- Tor Biering‐Sørensen (ORCID: https://orcid.org/0000-0003-4209-2778)
- Lawrence H. Moulton (ORCID: https://orcid.org/0000-0001-7041-7387)
- Sarah Louise Christensen (ORCID: https://orcid.org/0000-0002-7985-4783)
- Claudia Schwarz
- Katrine Feldballe Bernholm (ORCID: https://orcid.org/0000-0001-5324-9430)
- Julie Borchsenius
- Ping Zhang (ORCID: https://orcid.org/0000-0001-9163-6191)
- Lykke Larsen (ORCID: https://orcid.org/0000-0002-4113-4182)
- Elisa Gonzalez
- Bradford D Gessner
- Frederik H. Fussing
Institutions
- Statens Serum Institut (DK)
- University of Copenhagen (DK)
- Brigham and Women's Hospital (US)
- Steno Diabetes Centers (DK)
- Harvard University (US)
- Pfizer (United States) (US)
- Aalborg University Hospital (DK)
- Odense University Hospital (DK)
- Aarhus University Hospital (DK)
- Copenhagen University Hospital (DK)
- Gentofte Hospital (DK)
- Rigshospitalet (DK)
- Zealand University Hospital (DK)
- Pfizer (Canada) (CA)
Publication Details
- Journal
- New England Journal of Medicine
- Published
- 2025-08-30
- DOI
- https://doi.org/10.1056/nejmoa2509810
- Citations
- 18
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 24.38
Funders
- Pfizer